GRAFT VERSUS HOST DISEASE (CGVHD)
Clinical trials for GRAFT VERSUS HOST DISEASE (CGVHD) explained in plain language.
Never miss a new study
Get alerted when new GRAFT VERSUS HOST DISEASE (CGVHD) trials appear
Sign up with your email to follow new studies for GRAFT VERSUS HOST DISEASE (CGVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients: immune cell therapy targets stubborn graft-versus-host disease
Disease control Recruiting nowThis early-phase study tests whether a single dose of specially grown regulatory T cells, combined with daily low-dose interleukin-2, can safely treat chronic graft-versus-host disease (cGvHD) in people whose condition did not improve with steroids or IL-2 alone. About 21 partici…
Matched conditions: GRAFT VERSUS HOST DISEASE (CGVHD)
Phase: PHASE1 • Sponsor: Leslie Kean • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Scientists launch major study to track rare immune diseases
Knowledge-focused Recruiting nowThis study is observing up to 3,500 people with immune system problems, including rare genetic conditions like chronic granulomatous disease and severe combined immunodeficiency. Researchers will track how these diseases change over time through blood tests, imaging, and checkups…
Matched conditions: GRAFT VERSUS HOST DISEASE (CGVHD)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC